| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/10/1999 | EP0752878A4 Products comprising substrates capable of enzymatic cross-linking |
| 02/10/1999 | EP0669940B1 Specifically crosslinked hemoglobin with free functionality |
| 02/10/1999 | CN1207771A Methods and compositions for diagnosis and treatment of cancer |
| 02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same |
| 02/10/1999 | CN1207685A Novel medical use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 02/10/1999 | CN1207684A Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/10/1999 | CN1207683A Cytokine and Hemopoietic factor endogenous production enhancer and method of use thereof |
| 02/10/1999 | CN1207673A Endoparasiticidal agents |
| 02/10/1999 | CN1207395A Anti-FAS antibodies |
| 02/09/1999 | US5869701 Method of inactivation of viral and bacterial blood contaminants |
| 02/09/1999 | US5869658 Polymeric organic host materials that contain or that are coated with the novel naphthopyran compounds, lenses |
| 02/09/1999 | US5869638 Bone-related cadherin-like protein and process for its production |
| 02/09/1999 | US5869637 Human Kallikrein |
| 02/09/1999 | US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines |
| 02/09/1999 | US5869633 Thrombin receptor homolog polynucleotide |
| 02/09/1999 | US5869632 Human G-protein receptor HCEGH45 |
| 02/09/1999 | US5869624 HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 02/09/1999 | US5869622 Monoclonal antibodies to the pur protein |
| 02/09/1999 | US5869619 Modified antibody variable domains |
| 02/09/1999 | US5869618 For diagnosis of cancers related to erbb-2 oncogene expression |
| 02/09/1999 | US5869617 High and low molecular weight fractions of von Willebrand Factor and preparations of same |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients |
| 02/09/1999 | US5869602 Glucagon having lipophilic substituent on epsilon-amino group of lysine in position 30 |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869522 Solvent extraction; plant extracts; trimerization of 2,3-deoxy-1,4-naphthoquinone |
| 02/09/1999 | US5869519 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/09/1999 | US5869487 Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
| 02/09/1999 | US5869473 Method for treating and preventing hyperparathyroidism |
| 02/09/1999 | US5869466 Vitamin B12 mediated oral delivery systems for GCSF |
| 02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |
| 02/09/1999 | US5869462 Inhibition of proliferation of vascular smooth muscle cell |
| 02/09/1999 | US5869457 Modified proteins and their use for controlling viral infections |
| 02/09/1999 | US5869456 Use of glutathione diesters |
| 02/09/1999 | US5869455 Serine protease inhibitors-N-substituted derivatives |
| 02/09/1999 | US5869454 Arginine keto-amide enzyme inhibitors |
| 02/09/1999 | US5869452 Treatment of obesity |
| 02/09/1999 | US5869451 Activate the thrombopoietin receptor. |
| 02/09/1999 | US5869450 Amino acid sequences of peptides |
| 02/09/1999 | US5869449 Improved antibacterial activity against some clinical isolates of staphylococci somewhat resistant to teicoplanin. |
| 02/09/1999 | US5869448 Inhibit binding between vla-4 receptor and fibronectin cs-1 peptides; treating immunoinflammatory conditions |
| 02/09/1999 | US5869447 Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 02/09/1999 | US5869446 Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections |
| 02/09/1999 | US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| 02/09/1999 | US5869444 Osmotic agents for peritoneal dialysis |
| 02/09/1999 | US5869337 Regulated transcription of targeted genes and other biological events |
| 02/09/1999 | US5869333 Ryegrass pollen allergen |
| 02/09/1999 | US5869331 Target cell specific chimeric spleen necrosis virus viral particles having antigenic binding and natural viral proteins; gene therapy |
| 02/09/1999 | US5869330 Isolated polynucleotide involved in regulating energy balance; codes for polypeptide secreted by fat cells; treatment of various conditions involved in energy balance, inhibitor/enhancer for eating disorders |
| 02/09/1999 | US5869314 Tissue plasminogen activators and derivatives thereof as produced by recombinant means |
| 02/09/1999 | US5869293 DNA encoding human interferon IFN -α001 |
| 02/09/1999 | US5869292 Producing genetically engineered protein by replacing at least one acidic region of factor viii with acidic region of hirudin or heparin cofactor ii; increased coagulant activity |
| 02/09/1999 | US5869291 A polynucleotide coding for guanidine triphosphatases in the ras superfamily; involved in controlling intracellular vesicular transport; diagnosis/treatment of autoimmune disorders, cancer, vesicle, membrane, protein transport |
| 02/09/1999 | US5869290 Cayae1 polynucleotides |
| 02/09/1999 | US5869286 Receptor that binds IL-17 |
| 02/09/1999 | US5869284 Polynucleotide for gene expression in cultures; for tissue regeneration, stimulation of immune and hematopoeitic systems, modulators of receptor activity |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869281 For culturing and screening for modulators of receptor; glucoma, synchronization of animal estrus cycles, antitumor and antiprolferative agents |
| 02/09/1999 | US5869279 Extracting plant porphyrin from photosynthetic cells, converting in vitro to animal porphyrin; for recombination with apoproteins to efficiently form active, pure porphyroproteins (e.g. hemoglobin) |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869268 Anti-hanganutzui-deicher human monoclonal igg antibody; for anticarcinogenic and antitumors agents and diagnosis |
| 02/09/1999 | US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease |
| 02/09/1999 | US5869264 Immunoassays for and immunopurification of interferon-induced human protein |
| 02/09/1999 | US5869263 Lymphocyte chemoattractant factor and uses thereof |
| 02/09/1999 | US5869262 Quantitative immunoassay by contacting serum from patient with antibodies against circulating intercellular adhesion molecule-r, detecting binding; higher levels indicate progression of systematic lupus erythematosus |
| 02/09/1999 | US5869257 Nucleic acid indicator for determining the expression of melanocortin-4 receptors by hybridization to complementary sequence; physiological therapy involving organs and tissues expressing receptor; drug screening |
| 02/09/1999 | US5869256 Human vesicle trafficking coat protein involved in secretion and absorption; diagnosis and treatment of disorders and diseases with abnormal vesicle trafficking;inflamation, cancers, aids, endocrine system, instestines; antisense agent |
| 02/09/1999 | US5869254 In vitro splicing non-viral target nucleic acid with another to correct defect; for gene therapy, viricides |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869247 Natural resistance associated macrophage protein and uses thereof |
| 02/09/1999 | US5869246 Triplex Oligonucleotides targeted to p120 |
| 02/09/1999 | US5869233 Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS |
| 02/09/1999 | US5869232 Amino acid sequence of antibody binding to specific antigen (or hapten) covalently linked to second amino acid sequence to which a second antibody binds; redirecting specificity of antibody |
| 02/09/1999 | US5869230 Gene transfer into the kidney |
| 02/09/1999 | US5869093 Treatment of immune diseases by oral administration of autoantigens |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869064 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 02/09/1999 | US5869057 Administering a fusion protein comprising pentamers of escherichia coli labile toxin subunit b and human chorionic gonadotropin |
| 02/09/1999 | US5869055 Anti-inflammatory CD14 polypeptides |
| 02/09/1999 | US5869054 Treatment of multiple sclerosis by oral administration of autoantigens |
| 02/09/1999 | US5869053 5T4 antigen from human trophoblasts |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
| 02/09/1999 | US5869048 Method of treating ulcerative colitis with a monoclonal antibody |
| 02/09/1999 | US5869046 Altered polypeptides with increased half-life |
| 02/09/1999 | US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma |
| 02/09/1999 | US5869044 Method for the treatment or prophylaxis of ischemia-reperfusion injury |
| 02/09/1999 | US5869043 Csbpbeta protein, cytokine suppressive anti-inflammatory drug (csaid) binding protein |
| 02/09/1999 | US5869041 Delivery of bioactive compounds to an organism |
| 02/09/1999 | US5869040 Administering interfering mutant proto-oncogene or oncoprotein to target cell |
| 02/09/1999 | US5869039 X-linked adrenoleukodystrophy gene and corresponding protein |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | US5869035 Through transfer techniques, cancer cells are engineered to express an epitope which is targeted by natural antibodies causing complement destruction of transformed tumor cells associated with hyperacute xenograft rejection |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/09/1999 | CA1340384C Methode d'utilisation de vecteurs d'expression eucaryotes comprenant un amplificateur du virus bk |
| 02/09/1999 | CA1340381C Recombinant fusion proteins |